5,600 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Bought by Natixis

Natixis acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,600 shares of the medical instruments supplier's stock, valued at approximately $869,000.

Other hedge funds have also recently made changes to their positions in the company. Arizona State Retirement System lifted its holdings in ICU Medical by 1.0% in the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after purchasing an additional 65 shares in the last quarter. Huntington National Bank raised its position in shares of ICU Medical by 6.2% during the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after buying an additional 82 shares during the last quarter. Equitable Trust Co. lifted its holdings in shares of ICU Medical by 1.6% in the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after buying an additional 84 shares in the last quarter. LPL Financial LLC boosted its position in shares of ICU Medical by 2.0% during the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after acquiring an additional 93 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in ICU Medical by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock valued at $4,051,000 after acquiring an additional 136 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

ICU Medical Price Performance

Shares of ICU Medical stock traded up $0.99 during trading hours on Tuesday, reaching $136.89. The company's stock had a trading volume of 30,648 shares, compared to its average volume of 273,143. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a one year low of $95.44 and a one year high of $196.26. The firm has a 50 day moving average price of $143.25 and a 200-day moving average price of $157.64. The stock has a market cap of $3.37 billion, a P/E ratio of -29.94 and a beta of 0.86.

Analysts Set New Price Targets

Several analysts have commented on the stock. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. KeyCorp decreased their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Raymond James set a $97.00 price target on ICU Medical in a research note on Wednesday, March 12th. Finally, StockNews.com downgraded ICU Medical from a "buy" rating to a "hold" rating in a research note on Thursday, April 24th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $162.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.